Oragenics Co-Authors a Publication Describing the Dual Mechanism of Action of Lantibiotics
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., in collaboration with researchers from Florida International University’s Department of Physics and Biomolecular Sciences Institute, announced the publication of a study entitled “Lipid II Binding and Transmembrane Properties of Various Antimicrobial Lanthipeptides.” The study was published in the Journal of Chemical Theory and Computation.
The alarming rise in antibiotic-resistant infections in recent years and the dire need for the development of new antimicrobials are globally recognized. Organics lantibiotics are promising candidates to fight antibiotic-resistant bacteria due to their unique and dual mode of action, including interference with cell wall synthesis by binding to Lipid II and creation of unique pores in bacterial membranes.
Learn more about Oragenics Co-Authors a Publication Describing the Dual Mechanism of Action of Lantibiotics.